Why This DocuSign Analyst Has Just Turned Bearish

Loading...
Loading...

Shares of DocuSign Inc DOCU came under pressure last week, after the company announced plans to slash 10% of its workforce.

The latest layoff announcement sends “a negative demand signal” about the company’s growth in fiscal 2024, which the stock does not reflect, according to UBS.

The Analyst: Karl Keirstead downgraded DocuSign from Neutral to Sell, while keeping the price target unchanged at $52.

Check out other analyst stock ratings.

The Thesis: The stock has rallied around 54% from its December lows and does not appear compelling relative to other low-growth software peers, Keirstead said in the downgrade note.

“While intrigued by changes that the new CEO might make, our latest round of checks point to flattish/negative billings growth in CY23/FY24, a highly-penetrated TAM, an increasingly competitive rival in the form of Adobe, continued contract volume down-sizing risk upon renewals and a slowdown in the CLM segment,” the analyst wrote.

“We’re also cognizant that DocuSign has historically been very tied to the go-to-market engine of Salesforce, which is going through an unprecedented growth deceleration as well as internal disruption,” he added.

DOCU Price Action: Shares of DocuSign had lost 6.16% to reach $64.47 in the premarket session on Tuesday.

Next: DocuSign Lets Go Of 10% Of It's Workforce

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorDowngradesTop StoriesAnalyst RatingsMoversTrading IdeasKarl KeirsteadUBS
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...